e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Diagnostics in OSA: from polygraphy to genetics and cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea
I. Almendros, J.M. Montserrat, M. Torres, M. Dalmases, J. Ramirez, F. Campos-Rodríguez, D. Navajas, R. Farré (Barcelona, Sevilla, Spain)
Source:
Annual Congress 2012 - Diagnostics in OSA: from polygraphy to genetics and cancer
Session:
Diagnostics in OSA: from polygraphy to genetics and cancer
Session type:
Oral Presentation
Number:
190
Disease area:
Sleep and breathing disorders, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Almendros, J.M. Montserrat, M. Torres, M. Dalmases, J. Ramirez, F. Campos-Rodríguez, D. Navajas, R. Farré (Barcelona, Sevilla, Spain). Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea. Eur Respir J 2012; 40: Suppl. 56, 190
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea
Source: Eur Respir J 2012; 39: 215-217
Year: 2012
Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea
Source: Eur Respir J 2011; 39: 215-217
Year: 2012
Chronic intermittent hypoxia mimicking sleep apnoea increases spontaneous tumorigenesis in mice
Source: Eur Respir J , 49 (2) 1602111; DOI: 10.1183/13993003.02111-2016
Year: 2017
Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea
Source: Eur Respir J, 51 (3) 1701885; 10.1183/13993003.01885-2017
Year: 2018
Soluble PD-L1 is a potential biomarker of cutaneous melanoma aggressiveness and metastasis in obstructive sleep apnoea patients
Source: Eur Respir J, 53 (2) 1801298; 10.1183/13993003.01298-2018
Year: 2019
Aged mice obstructive sleep apnoea model with spontaneous tumorigenesis: physiological parameters
Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Year: 2017
Inspiratory neural drive response to hypoxia adequately estimates peripheral chemosensitivity in OSAHS patients
Source: Eur Respir J 2002; 20: 724-732
Year: 2002
Sleep disordered breathing and nocturnal hypoxemia are associated with an increased risk of lung cancer.
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007
Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea
Source: Eur Respir J 2009; 33: 793-796
Year: 2009
Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008
Chronic intermittent hypoxia reduces progressive sperm motility in a mouse model of obstructive sleep apnea
Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing
Year: 2013
Recurrent airway obstructions increase circulating mesenchymal stem cells in an acute rat model of sleep apnea
Source: Annual Congress 2008 - Pathogenesis of obstructive sleep apnoea
Year: 2008
Prevalence of day-time hypercapnia or hypoxia in patients with OSAS and normal lung function
Source: Eur Respir J 2002; 20: Suppl. 38, 493s
Year: 2002
Intermittent hypoxia in sleep apnea: a cause of inflammatory activation
Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Year: 2007
Sleep apnoea in interstitial lung disease
Source: Sleep and Breathing Conference 2017
Year: 2017
CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea
Source: Eur Respir J 2008; 32: 1009-1015
Year: 2008
Hypoxic stress in obstructive sleep apnea syndrome (OSAS) activates invasive ability of monocytes
Source: Eur Respir J 2005; 26: Suppl. 49, 354s
Year: 2005
Relationship between sleep apnoea and cancer
Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021
Year: 2021
The role of angiogenesis in obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept